| Cancer epigenetic biomarkers in liquid biopsy for high incidence malignancies C Palanca-Ballester, A Rodriguez-Casanova, S Torres, ... Cancers 13 (12), 3016, 2021 | 59 | 2021 |
| The role of clonal communication and heterogeneity in breast cancer A Martín-Pardillos, Á Valls Chiva, G Bande Vargas, P Hurtado Blanco, ... BMC cancer 19, 1-26, 2019 | 49 | 2019 |
| Epigenetic landscape of liquid biopsy in colorectal cancer A Rodriguez-Casanova, N Costa-Fraga, A Bao-Caamano, ... Frontiers in Cell and Developmental Biology 9, 622459, 2021 | 44 | 2021 |
| Aberrant integration of Hepatitis B virus DNA promotes major restructuring of human hepatocellular carcinoma genome architecture EG Álvarez, J Demeulemeester, P Otero, C Jolly, D García-Souto, ... Nature communications 12 (1), 6910, 2021 | 39 | 2021 |
| Clinical potential of circulating free DNA and circulating tumour cells in patients with metastatic non‐small‐cell lung cancer treated with pembrolizumab P Mondelo‐Macía, J García‐González, L León‐Mateos, U Anido, S Aguin, ... Molecular oncology 15 (11), 2923-2940, 2021 | 23 | 2021 |
| Epigenetics of circulating tumor cells in breast cancer A Bao-Caamano, A Rodriguez-Casanova, A Diaz-Lagares Circulating Tumor Cells in Breast Cancer Metastatic Disease, 117-134, 2020 | 19 | 2020 |
| Noninvasive early detection of colorectal cancer by hypermethylation of the LINC00473 promoter in plasma cell-free DNA J Ruiz-Bañobre, A Rodriguez-Casanova, N Costa-Fraga, ... Clinical Epigenetics 14 (1), 86, 2022 | 16 | 2022 |
| A genome-wide cell-free DNA methylation analysis identifies an episignature associated with metastatic luminal B breast cancer A Rodriguez-Casanova, N Costa-Fraga, C Castro-Carballeira, ... Frontiers in Cell and Developmental Biology 10, 1016955, 2022 | 10 | 2022 |
| Evaluation of a targeted next-generation sequencing panel for the non-invasive detection of variants in circulating DNA of colorectal cancer A Rodríguez-Casanova, A Bao-Caamano, RM Lago-Lestón, ... Journal of clinical medicine 10 (19), 4487, 2021 | 10 | 2021 |
| Somatic mutations in tumor and plasma of locoregional recurrent and/or metastatic head and neck cancer using a next‐generation sequencing panel: A preliminary study Ó Rapado‐González, J Brea‐Iglesias, A Rodríguez‐Casanova, ... Cancer Medicine 12 (6), 6615-6622, 2023 | 6 | 2023 |
| Epigenomic analysis reveals a unique DNA methylation program of metastasis-competent circulating tumor cells in colorectal cancer A Bao-Caamano, N Costa-Fraga, L Cayrefourcq, MA Jácome, ... Scientific Reports 13 (1), 15401, 2023 | 4 | 2023 |
| Epigenomic reprogramming of therapy-resistant circulating tumor cells in colon cancer A Bao-Caamano, N Costa-Fraga, L Cayrefourcq, A Rodriguez-Casanova, ... Frontiers in Cell and Developmental Biology 11, 1291179, 2023 | 2 | 2023 |
| Epigenetic and genetic profiling of cell-free DNA for precision oncology in colorectal and breast cancer A Rodríguez Casanova Epigenetic and genetic profiling of cell-free DNA for precision oncology in …, 2024 | | 2024 |
| A Cell-Free DNA Methylation Signature to Detect Metastatic Breast Cancer in Blood I Barragan, A Gonzalez, J Dubbelman, J Onieva, A Rodriguez-Casanova, ... The Journal of Liquid Biopsy 1, 2023 | | 2023 |
| Publisher Correction: Epigenomic analysis reveals a unique DNA methylation program of metastasis-competent circulating tumor cells in colorectal cancer A Bao-Caamano, N Costa-Fraga, L Cayrefourcq, MA Jácome, ... Scientific Reports 13 (1), 16999, 2023 | | 2023 |
| 141P Immune-related epigenomic and transcriptomic signatures to predict immunotherapy response in NSCLC M Gallardo-Gómez, A Carreras-Soldevilla, I Alonso-Álvarez, ML Quintela, ... ESMO Open 8 (1), 2023 | | 2023 |
| Rapid Idylla mutational testing to detect EGFR mutations in plasma samples and to monitor therapy in advanced non-small cell lung cancer patients P Mondelo-Macía, RM Lago-Lestón, A Rodríguez-Casanova, A Abalo, ... Pathology 55 (5), 698-703, 2023 | | 2023 |
| Epigenetics and Liquid Biopsy in Oncology: Role in Metastasis and Clinical Utility A Rodriguez-Casanova, A Bao-Caamano, N Costa-Fraga, ... Cancer Metastasis Through the Lymphovascular System, 167-174, 2022 | | 2022 |
| Genome-wide DNA methylation analysis identifies novel biomarkers associated with risk of relapse beyond oncotype DX recurrence-score risk assessment within HR+/HER2-early-stage … J Fuentes-Antras, V Garcia-Barberan, N Costa-Fraga, F Moreno, ... CANCER RESEARCH 82 (4), 2022 | | 2022 |
| Abstract P3-05-06: Genome-wide DNA methylation analysis identifies novel biomarkers associated with risk of relapse beyond oncotype DX recurrence-score risk assessment within … J Fuentes-Antrás, V García-Barberán, N Costa-Fraga, F Moreno, ... Cancer Research 82 (4_Supplement), P3-05-06-P3-05-06, 2022 | | 2022 |
